
Clinuvel Pharmaceuticals (ASX: CUV), Camplify (ASX: CHL) and Whispir (ASX: WSP) Quarterly Cashflow Reports
ASX growth stocks Clinuvel Pharmaceuticals (ASX: CUV), Camplify (ASX: CHL) and Whispir (ASX: WSP) have all reported quarterly cashflow.
ASX growth stocks Clinuvel Pharmaceuticals (ASX: CUV), Camplify (ASX: CHL) and Whispir (ASX: WSP) have all reported quarterly cashflow.
These 5 well established businesses have all seen insiders snapping up shares at close to or above current prices.
Camplify revenue growth of over 100% will catch investors eye, but the devil is in the detail…
The new Omicron variant is not causing me to panic, but I am tweaking my portfolio a little to prepare for (likely) harder times ahead.
The Camplify quarterly result was very resilient in the face of lockdowns, and the share price has popped in response.
Some stocks have high multiples and higher growth rates, others have lower multiples and lower growth rates. Here’s how I decided which one to choose.
One has director buying, the other has revenue growth well over 100%, but neither of them are much talked about by small cap fund managers (yet)…